Real life experience with nivolumab in patients (pts) with advanced non-squamous NSCLC (nSq-NSCLC) exhibiting KRAS mutations: The Italian Expanded Access Program (EAP)
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2017-09, Vol.28, p.v471-v472 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | v472 |
|---|---|
| container_issue | |
| container_start_page | v471 |
| container_title | Annals of oncology |
| container_volume | 28 |
| creator | Cappuzzo, F. Bidoli, P. Chiari, R. Chirco, A. Turci, D. Ardizzoni, A. Santoro, A. Natoli, C. Francini, G. Giordano, M. Borra, G. Defferrari, C. Livi, L. Berruti, A. Minelli, M. Ricevuto, E. Illiano, A. Puppo, G. Delmonte, A. Misino, A. |
| description | |
| doi_str_mv | 10.1093/annonc/mdx380.024 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdx380_024</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdx380_024</sourcerecordid><originalsourceid>FETCH-LOGICAL-c854-a6cf2d8aa2662024af93241c67f56058868ca5e65af462ba3fd48002c8a9fb933</originalsourceid><addsrcrecordid>eNotkMFOg0AQhjloYq0-gLc5tgfaZRe24I2Qqo2NNm3vZFh22zWwUBZqfSJfUxRPM8n8-f7M5zgPHpl5JGJzNKYyYl7mFxaSGaH-lTMiEWXuImD-jXNr7QchhEc0GjnfW4kFFFpJkJdaNloaIeFTt0cw-lwVXYkZaAM1tv2ptTCpWzsdApifsU_n0Ne59tRhWXUW3nbJOoGJ2Z3cv3Xag4860602B3jdxjsou7anVcY-wv4oYdViodHA8lKjyXtcLIS0FjZNdWiwhMky3kzvnGuFhZX3_3Ps7J-W--TFXb8_r5J47Yow8F3kQtE8RKSc0_5xVBGjvif4QgWcBGHIQ4GB5AEqn9MMmcr9kBAqQoxUFjE2drwBK5rK2kaqtG50ic1X6pH0V246yE0HuWnfwX4Auxpy4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Real life experience with nivolumab in patients (pts) with advanced non-squamous NSCLC (nSq-NSCLC) exhibiting KRAS mutations: The Italian Expanded Access Program (EAP)</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Cappuzzo, F. ; Bidoli, P. ; Chiari, R. ; Chirco, A. ; Turci, D. ; Ardizzoni, A. ; Santoro, A. ; Natoli, C. ; Francini, G. ; Giordano, M. ; Borra, G. ; Defferrari, C. ; Livi, L. ; Berruti, A. ; Minelli, M. ; Ricevuto, E. ; Illiano, A. ; Puppo, G. ; Delmonte, A. ; Misino, A.</creator><creatorcontrib>Cappuzzo, F. ; Bidoli, P. ; Chiari, R. ; Chirco, A. ; Turci, D. ; Ardizzoni, A. ; Santoro, A. ; Natoli, C. ; Francini, G. ; Giordano, M. ; Borra, G. ; Defferrari, C. ; Livi, L. ; Berruti, A. ; Minelli, M. ; Ricevuto, E. ; Illiano, A. ; Puppo, G. ; Delmonte, A. ; Misino, A.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdx380.024</identifier><language>eng</language><ispartof>Annals of oncology, 2017-09, Vol.28, p.v471-v472</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Cappuzzo, F.</creatorcontrib><creatorcontrib>Bidoli, P.</creatorcontrib><creatorcontrib>Chiari, R.</creatorcontrib><creatorcontrib>Chirco, A.</creatorcontrib><creatorcontrib>Turci, D.</creatorcontrib><creatorcontrib>Ardizzoni, A.</creatorcontrib><creatorcontrib>Santoro, A.</creatorcontrib><creatorcontrib>Natoli, C.</creatorcontrib><creatorcontrib>Francini, G.</creatorcontrib><creatorcontrib>Giordano, M.</creatorcontrib><creatorcontrib>Borra, G.</creatorcontrib><creatorcontrib>Defferrari, C.</creatorcontrib><creatorcontrib>Livi, L.</creatorcontrib><creatorcontrib>Berruti, A.</creatorcontrib><creatorcontrib>Minelli, M.</creatorcontrib><creatorcontrib>Ricevuto, E.</creatorcontrib><creatorcontrib>Illiano, A.</creatorcontrib><creatorcontrib>Puppo, G.</creatorcontrib><creatorcontrib>Delmonte, A.</creatorcontrib><creatorcontrib>Misino, A.</creatorcontrib><title>Real life experience with nivolumab in patients (pts) with advanced non-squamous NSCLC (nSq-NSCLC) exhibiting KRAS mutations: The Italian Expanded Access Program (EAP)</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNotkMFOg0AQhjloYq0-gLc5tgfaZRe24I2Qqo2NNm3vZFh22zWwUBZqfSJfUxRPM8n8-f7M5zgPHpl5JGJzNKYyYl7mFxaSGaH-lTMiEWXuImD-jXNr7QchhEc0GjnfW4kFFFpJkJdaNloaIeFTt0cw-lwVXYkZaAM1tv2ptTCpWzsdApifsU_n0Ne59tRhWXUW3nbJOoGJ2Z3cv3Xag4860602B3jdxjsou7anVcY-wv4oYdViodHA8lKjyXtcLIS0FjZNdWiwhMky3kzvnGuFhZX3_3Ps7J-W--TFXb8_r5J47Yow8F3kQtE8RKSc0_5xVBGjvif4QgWcBGHIQ4GB5AEqn9MMmcr9kBAqQoxUFjE2drwBK5rK2kaqtG50ic1X6pH0V246yE0HuWnfwX4Auxpy4w</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Cappuzzo, F.</creator><creator>Bidoli, P.</creator><creator>Chiari, R.</creator><creator>Chirco, A.</creator><creator>Turci, D.</creator><creator>Ardizzoni, A.</creator><creator>Santoro, A.</creator><creator>Natoli, C.</creator><creator>Francini, G.</creator><creator>Giordano, M.</creator><creator>Borra, G.</creator><creator>Defferrari, C.</creator><creator>Livi, L.</creator><creator>Berruti, A.</creator><creator>Minelli, M.</creator><creator>Ricevuto, E.</creator><creator>Illiano, A.</creator><creator>Puppo, G.</creator><creator>Delmonte, A.</creator><creator>Misino, A.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201709</creationdate><title>Real life experience with nivolumab in patients (pts) with advanced non-squamous NSCLC (nSq-NSCLC) exhibiting KRAS mutations: The Italian Expanded Access Program (EAP)</title><author>Cappuzzo, F. ; Bidoli, P. ; Chiari, R. ; Chirco, A. ; Turci, D. ; Ardizzoni, A. ; Santoro, A. ; Natoli, C. ; Francini, G. ; Giordano, M. ; Borra, G. ; Defferrari, C. ; Livi, L. ; Berruti, A. ; Minelli, M. ; Ricevuto, E. ; Illiano, A. ; Puppo, G. ; Delmonte, A. ; Misino, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c854-a6cf2d8aa2662024af93241c67f56058868ca5e65af462ba3fd48002c8a9fb933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cappuzzo, F.</creatorcontrib><creatorcontrib>Bidoli, P.</creatorcontrib><creatorcontrib>Chiari, R.</creatorcontrib><creatorcontrib>Chirco, A.</creatorcontrib><creatorcontrib>Turci, D.</creatorcontrib><creatorcontrib>Ardizzoni, A.</creatorcontrib><creatorcontrib>Santoro, A.</creatorcontrib><creatorcontrib>Natoli, C.</creatorcontrib><creatorcontrib>Francini, G.</creatorcontrib><creatorcontrib>Giordano, M.</creatorcontrib><creatorcontrib>Borra, G.</creatorcontrib><creatorcontrib>Defferrari, C.</creatorcontrib><creatorcontrib>Livi, L.</creatorcontrib><creatorcontrib>Berruti, A.</creatorcontrib><creatorcontrib>Minelli, M.</creatorcontrib><creatorcontrib>Ricevuto, E.</creatorcontrib><creatorcontrib>Illiano, A.</creatorcontrib><creatorcontrib>Puppo, G.</creatorcontrib><creatorcontrib>Delmonte, A.</creatorcontrib><creatorcontrib>Misino, A.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cappuzzo, F.</au><au>Bidoli, P.</au><au>Chiari, R.</au><au>Chirco, A.</au><au>Turci, D.</au><au>Ardizzoni, A.</au><au>Santoro, A.</au><au>Natoli, C.</au><au>Francini, G.</au><au>Giordano, M.</au><au>Borra, G.</au><au>Defferrari, C.</au><au>Livi, L.</au><au>Berruti, A.</au><au>Minelli, M.</au><au>Ricevuto, E.</au><au>Illiano, A.</au><au>Puppo, G.</au><au>Delmonte, A.</au><au>Misino, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Real life experience with nivolumab in patients (pts) with advanced non-squamous NSCLC (nSq-NSCLC) exhibiting KRAS mutations: The Italian Expanded Access Program (EAP)</atitle><jtitle>Annals of oncology</jtitle><date>2017-09</date><risdate>2017</risdate><volume>28</volume><spage>v471</spage><epage>v472</epage><pages>v471-v472</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdx380.024</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2017-09, Vol.28, p.v471-v472 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdx380_024 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Real life experience with nivolumab in patients (pts) with advanced non-squamous NSCLC (nSq-NSCLC) exhibiting KRAS mutations: The Italian Expanded Access Program (EAP) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T11%3A23%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Real%20life%20experience%20with%20nivolumab%20in%20patients%20(pts)%20with%20advanced%20non-squamous%20NSCLC%20(nSq-NSCLC)%20exhibiting%20KRAS%20mutations:%20The%20Italian%20Expanded%20Access%20Program%20(EAP)&rft.jtitle=Annals%20of%20oncology&rft.au=Cappuzzo,%20F.&rft.date=2017-09&rft.volume=28&rft.spage=v471&rft.epage=v472&rft.pages=v471-v472&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdx380.024&rft_dat=%3Ccrossref%3E10_1093_annonc_mdx380_024%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |